Skip to content

Assessment of What Patients and Healthcare Providers Value

What Do You Value? A Survey Study Assessing How Patients and Health Care Providers Weigh the Different Components of the Value Equation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04483349
Enrollment
397
Registered
2020-07-23
Start date
2020-06-11
Completion date
2022-08-11
Last updated
2022-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine Carcinoma

Brief summary

To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).

Detailed description

PRIMARY OBJECTIVE: I. To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience). SECONDARY OBJECTIVES: I. To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery. II. To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence). III. To assess how patients' view differ to health providers. OUTLINE: Patients and healthcare providers complete a survey over 10-15 minutes.

Interventions

OTHERSurvey Administration

Complete survey

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma * Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers * Able to understand the description of the study and willing to participate

Exclusion criteria

* Inability to read and answer questions in English

Design outcomes

Primary

MeasureTime frameDescription
Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)Survey completion up to 1 yearWe will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.

Secondary

MeasureTime frameDescription
Most important attributes of value to healthcare providersSurvey completion up to 1 yearProvider characteristics and survey items will be summarized using descriptive statistics, including means, SDs, proportions, range, and 95% CIs, etc.
Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience)Survey completion up to 1 yearChi-square tests (or Fisher's exact test) will be used to compare the results between patients and providers.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026